Oncologic patients’ misconceptions may impede enrollment into clinical trials: a cross-sectional study

by Nethanel Asher, Ari Raphael, Ido Wolf, Sharon Pelles, Ravit Geva
Published 2022-01-01

Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment

by Ari Raphael, Mali Salmon-Divon, Jessica Epstein, Tamar Zahavi, Amir Sonnenblick, Shlomit S. Shachar
Published 2022-09-01

Valvular Heart Disease following Anthracycline Therapy—Is It Time to Look beyond Ejection Fraction?

by David Zahler, Joshua H. Arnold, Tali Bar-On, Ari Raphael, Shafik Khoury, Zach Rozenbaum, Shmuel Banai, Yaron Arbel, Yan Topilsky, Michal Laufer-Perl
Published 2022-08-01

The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of...

by Ari Raphael, Ari Raphael, Amir Onn, Amir Onn, Liran Holtzman, Julia Dudnik, Damien Urban, Waleed Kian, Aharon Y. Cohen, Mor Moskovitz, Alona Zer, Jair Bar, Jair Bar, Natalie Maimon Rabinovich, Shirly Grynberg, Cecilie Oedegaard, Abed Agbarya, Nir Peled, Nir Peled, Tzippy Shochat, Elizabeth Dudnik, Elizabeth Dudnik, Elizabeth Dudnik
Published 2022-05-01

<i>FGFR</i> Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Targe...

by Ari Raphael, Elizabeth Dudnik, Dov Hershkovitz, Suyog Jain, Steve Olsen, Lior Soussan-Gutman, Taly Ben-Shitrit, Addie Dvir, Hovav Nechushtan, Nir Peled, Amir Onn, Abed Agbarya, on behalf of the Israel Lung Cancer Group
Published 2022-04-01